References
- Legiawati L, Fahira A, Taufiqqurrachman I, et al. Low-dose versus conventional-dose oral isotretinoin regimens: a systematic review on randomized controlled comparative studies of different regimens. Curr Drug Saf. 2023;18(3):297-306. doi: 10.2174/1574886317666220613162225.
- Moghimi J, Pahlevan D, Azizzadeh M, et al. Isotretinoin-associated Sweet’s syndrome: a case report. Daru. 2014;22(1):69.
- Mavranezouli I, Daly CH, Welton NJ, et al. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022;187(5):639-649. doi: 10.1111/bjd.21739.
- Kapała J, Lewandowska J, Placek W, et al. Adverse events in isotretinoin therapy: a single-arm meta-analysis. Int J Environ Res Public Health. 2022;19(11):6463. doi: 10.3390/ijerph19116463.
- Elubous KA, Toubasi AA, Elubous A, et al. Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. Cutan Ocul Toxicol. 2022;41(2):113–122. doi: 10.1080/15569527.2022.2050747.
- Ruiz-Lozano RE, Hernández-Camarena JC, Garza-Garza LA, et al. Isotretinoin and the eye: a review for the dermatologist. Dermatol Ther. 2020;33(6):e14029.
- Sekeryapan B, Dılek N, Oner V, et al. Retinal nerve fiber layer and ganglion cell layer thickness in patients receiving systemic isotretinoin therapy. Int Ophthalmol. 2013;33(5):481–484. doi: 10.1007/s10792-013-9726-6.
- Demirok G, Topalak Y, Gündüz Ö, et al. The long-term effect of oral isotretinoin therapy on macula ganglion cell complex thickness. Cutan Ocul Toxicol. 2017;36(3):262–259. doi: 10.1080/15569527.2016.1265549.
- Kaptı BH, Aslan G, Yavruoğlu MA. Evaluation of retinal nerve fiber layer changes with oral isotretinoin treatment. Ophthalmol Ther. 2013;2(1):19–23. doi: 10.1007/s40123-012-0009-5.
- Ucak H, Aykut V, Ozturk S, et al. Effect of oral isotretinoin treatment on retinal nerve fiber layer thickness. J Cutan Med Surg. 2014;18(4):236–242. doi: 10.2310/7750.2013.13168.
- Karadag O, Kocamaz M, Dastan M, et al. Assessment of macular choroidal thickness, Central macular thickness and retinal nerve fiber layer in patients receiving oral isotretinoin treatment. Cutan Ocul Toxicol. 2020;39(3):233–236. doi: 10.1080/15569527.2020.1778015.
- Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500. doi: 10.1016/j.ajo.2008.05.032.
- Vance SK, Imamura Y, Freund KB. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina. 2011;31(2):332–335. doi: 10.1097/IAE.0b013e3181eef0ae.
- Sekeryapan Gediz B, Corak Eroglu F, Aydogan M, et al. Choroidal vascular changes in acne patients under isotretinoin treatment. Cutan Ocul Toxicol. 2021;40(2):125–129. doi: 10.1080/15569527.2021.1914075.
- Yılmaz U, Küçük E, Koç Ç, et al. Investigation of the effects of systemic isotretinoin treatment on retinal nerve fiber layer and macula. J Dermatolog Treat. 2017;28(4):314–317. doi: 10.1080/09546634.2016.1254146.
- Genç Işık İ, Işık MU. Cross-sectional assessment of the ellipsoid zone and the retinal pigment epithelium-Bruch membrane complex after systemic isotretinotin use. Cutan Ocul Toxicol. 2022;41(1):67–72. doi: 10.1080/15569527.2021.2025386.